Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Luitpold Pharmaceuticals, Inc. v. ED. Geistlich Sohne A.G. Fur Chemische Industrie et al
Case Number:
1:11-cv-00681
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 18, 2015
Luitpold Entitled To Some Damages In $120M Contract Dispute
Luitpold Pharmaceuticals Inc. is entitled to damages on claims that Swiss chemical and pharmaceutical conglomerate Ed. Geistlich Soehne AG breached licensing agreements by advertising its dental products in the U.S., a New York federal judge ruled Thursday.
-
January 17, 2013
Swiss Pharma Co. Shakes Suit Over $120M Supply Contract
A New York federal judge on Wednesday ruled in favor of Ed. Geistlich Soehne AG in a dispute with Luitpold Pharmaceuticals Inc. over its $120 million licensing and distribution agreements for dental products, finding the Swiss chemical and pharmaceutical conglomerate had the right to terminate the contract for "any reason whatsoever."